Anil Koul

6.7k total citations · 1 hit paper
40 papers, 4.9k citations indexed

About

Anil Koul is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Anil Koul has authored 40 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 21 papers in Molecular Biology and 19 papers in Epidemiology. Recurrent topics in Anil Koul's work include Tuberculosis Research and Epidemiology (20 papers), Cancer therapeutics and mechanisms (11 papers) and ATP Synthase and ATPases Research (10 papers). Anil Koul is often cited by papers focused on Tuberculosis Research and Epidemiology (20 papers), Cancer therapeutics and mechanisms (11 papers) and ATP Synthase and ATPases Research (10 papers). Anil Koul collaborates with scholars based in Belgium, United States and Netherlands. Anil Koul's co-authors include Koen Andries, Jérôme Guillemont, Dirk Bald, Nacer Lounis, Éric Arnoult, Bert Klebl, Luc Vranckx, Axel Ullrich, Holger Lill and Cristina Villellas and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Anil Koul

40 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The challenge of new drug discovery for tuberculosis

2011 831 citations Anil Koul, Éric Arnoult et al. Nature profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Anil Koul	3.1k	2.8k	2.0k	578	539	40	4.9k
Ken Duncan	3.0k 1.0×	1.9k 0.7×	2.4k 1.2×	524 0.9×	683 1.3×	52	4.7k
Gyanu Lamichhane	2.5k 0.8×	1.4k 0.5×	2.1k 1.0×	681 1.2×	464 0.9×	93	3.9k
Anne J. Lenaerts	3.2k 1.1×	1.9k 0.7×	2.3k 1.1×	430 0.7×	830 1.5×	93	5.0k
Kyu Y. Rhee	2.8k 0.9×	3.2k 1.1×	1.9k 0.9×	669 1.2×	250 0.5×	116	5.4k
Catherine Vilchèze	3.6k 1.2×	3.3k 1.2×	2.6k 1.3×	862 1.5×	872 1.6×	85	6.3k
Richard A. Slayden	2.4k 0.8×	2.3k 0.8×	1.7k 0.8×	599 1.0×	1.1k 2.1×	85	4.7k
Khisimuzi Mdluli	2.3k 0.7×	1.6k 0.6×	1.7k 0.8×	538 0.9×	378 0.7×	43	3.4k
James C. Sacchettini	3.4k 1.1×	3.4k 1.2×	2.4k 1.2×	857 1.5×	1.1k 2.0×	41	6.4k
Jérôme Guillemont	2.9k 0.9×	2.5k 0.9×	1.6k 0.8×	539 0.9×	954 1.8×	47	4.6k
Valerie Mizrahi	4.3k 1.4×	3.7k 1.3×	3.1k 1.5×	1.0k 1.8×	435 0.8×	142	7.0k

Countries citing papers authored by Anil Koul

Since Specialization

Citations

This map shows the geographic impact of Anil Koul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Koul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Koul more than expected).

Fields of papers citing papers by Anil Koul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Koul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Koul. The network helps show where Anil Koul may publish in the future.

Co-authorship network of co-authors of Anil Koul

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Koul. A scholar is included among the top collaborators of Anil Koul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Koul. Anil Koul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xin, Sivi Ouwerkerk‐Mahadevan, Pieter Verboven, et al.. (2024). A Pangenotypic Hepatitis E Virus Replication Inhibitor With High Potency in a Rat Infection Model. Gastroenterology. 168(4). 769–783.e12. 1 indexed citations

Phelan, Jody, et al.. (2024). An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates. Scientific Reports. 14(1). 24792–24792. 2 indexed citations

Doijen, Jordi, Inha Heo, Koen Temmerman, et al.. (2023). A flexible, image-based, high-throughput platform encompassing in-depth cell profiling to identify broad-spectrum coronavirus antivirals with limited off-target effects. Antiviral Research. 222. 105789–105789. 1 indexed citations

Goethals, Olivia, Bart Kesteleyn, Patrick Chaltin, et al.. (2022). A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships. Antiviral Research. 210. 105495–105495. 9 indexed citations

Vendeville, Sandrine, Abdellah Tahri, Lili Hu, et al.. (2020). Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus. Journal of Medicinal Chemistry. 63(15). 8046–8058. 20 indexed citations

Battles, Michael B., Johannes P. M. Langedijk, Supranee Chaiwatpongsakorn, et al.. (2015). Molecular mechanism of respiratory syncytial virus fusion inhibitors. Nature Chemical Biology. 12(2). 87–93. 120 indexed citations

Ispas, Gabriela, Anil Koul, Johan Verbeeck, et al.. (2015). Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model. PLoS ONE. 10(5). e0126959–e0126959. 35 indexed citations

Lü, Ping, Marieke H. Heineke, Anil Koul, et al.. (2015). The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress. Scientific Reports. 5(1). 10333–10333. 92 indexed citations

Lü, Ping, Cristina Villellas, Anil Koul, et al.. (2014). The ATP synthase inhibitor bedaquiline interferes with small-molecule efflux in Mycobacterium smegmatis. The Journal of Antibiotics. 67(12). 835–837. 22 indexed citations

10.

Andries, Koen, Cristina Villellas, Nele Coeck, et al.. (2014). Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline. PLoS ONE. 9(7). e102135–e102135. 288 indexed citations

11.

Koul, Anil, Luc Vranckx, Neeraj Dhar, et al.. (2014). Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nature Communications. 5(1). 3369–3369. 206 indexed citations

12.

Bald, Dirk & Anil Koul. (2012). Advances and strategies in discovery of new antibacterials for combating metabolically resting bacteria. Drug Discovery Today. 18(5-6). 250–255. 16 indexed citations

13.

Haagsma, Anna C., Anil Koul, Koen Andries, et al.. (2011). Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase. PLoS ONE. 6(8). e23575–e23575. 103 indexed citations

14.

Koul, Anil, Éric Arnoult, Nacer Lounis, Jérôme Guillemont, & Koen Andries. (2011). The challenge of new drug discovery for tuberculosis. Nature. 469(7331). 483–490. 831 indexed citations breakdown →

15.

Bald, Dirk & Anil Koul. (2010). Respiratory ATP synthesis: the new generation of mycobacterial drug targets?. FEMS Microbiology Letters. 308(1). 1–7. 72 indexed citations

16.

Koul, Anil, Najoua Dendouga, Karen Vergauwen, et al.. (2007). Diarylquinolines target subunit c of mycobacterial ATP synthase. Nature Chemical Biology. 3(6). 323–324. 433 indexed citations

17.

Jonge, Marc R. de, et al.. (2007). A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910. Proteins Structure Function and Bioinformatics. 67(4). 971–980. 93 indexed citations

18.

Walburger, Anne, Anil Koul, Giorgio Ferrari, et al.. (2004). Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages. Science. 304(5678). 1800–1804. 451 indexed citations

19.

Koul, Anil, Thomas Herget, Bert Klebl, & Axel Ullrich. (2004). Interplay between mycobacteria and host signalling pathways. Nature Reviews Microbiology. 2(3). 189–202. 304 indexed citations

20.

Chopra, Puneet, Bhuminder Singh, Ramandeep Singh, et al.. (2003). Phosphoprotein phosphatase of Mycobacterium tuberculosis dephosphorylates serine–threonine kinases PknA and PknB. Biochemical and Biophysical Research Communications. 311(1). 112–120. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact